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Abstract: Several studies have shown that women with a preeclamptic pregnancy exhibit an increased
risk of cardiovascular disease. However, the underlying molecular mechanisms are unknown. Animal
models are essential to investigate the causes of this increased risk and have the ability to assess
possible preventive and therapeutic interventions. Using the latest technologies such as speckle
tracking echocardiography (STE), it is feasible to map subclinical changes in cardiac diastolic and
systolic function as well as structural changes of the maternal heart. The aim of this work is to compare
cardiovascular changes in an established transgenic rat model with preeclampsia-like pregnancies
with findings from human preeclamptic pregnancies by STE. The same algorithms were used to
evaluate and compare the changes in echoes of human and rodents. Parameters of functionality
such as global longitudinal strain (animal −23.54 ± 1.82% vs. −13.79 ± 0.57%, human −20.60 ± 0.47%
vs. −15.45 ± 1.55%) as well as indications of morphological changes such as relative wall thickness
(animal 0.20 ± 0.01 vs. 0.25 ± 0.01, human 0.34 ± 0.01 vs. 0.40 ± 0.02) are significantly altered in both
species after preeclamptic pregnancies. Thus, the described rat model simulates the human situation
quite well and is a valuable tool for future investigations regarding cardiovascular changes. STE is a
unique technique that can be applied in animal models and humans with a high potential to uncover
cardiovascular maladaptation and subtle pathologies.
Keywords: preeclampsia; pregnancy; speckle tracking echocardiography; cardiovascular dysfunction;
animal models of human disease
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1. Introduction
A pathological pregnancy, including preterm birth, gestational diabetes mellitus, and preeclampsia
(PE), is the first gender-specific risk factor for cardiovascular disease (CVD) later in life [1]. PE, with its
typical symptoms including the onset of hypertension and signs of end-organ damage, has a fourfold
increase regarding the risk for long-term CVD [2]. In the last years, cardiovascular changes during a
preeclamptic pregnancy and especially persistent alterations in maternal cardiac structure and function
moved into the focus of scientific research [3]. It has been demonstrated that former preeclamptic
women show relaxation abnormalities, diastolic dysfunction, left ventricular (LV) hypertrophy [4–6],
and abnormal response to volume expansion and exercise [7–9]. In most of the studies, symptoms
are rather mild and sometimes even asymptomatic. It remains unclear whether the increased risk for
future CVD is related to PE or predisposing and preexisting factors [10], and thus PE represents a
window to compromised future cardiovascular health. The mechanism for pathological functional and
structural remodeling in the maternal heart after a pathological pregnancy is also not fully understood.
For this reason, representative animal models are of increasing importance. A well-established
rodent model for PE is the rat model, whose female is transgenic for human angiotensinogen and
is mated with a transgenic male for human renin. Both animals are phenotypically inconspicuous
until mating. Interestingly, dams develop typical symptoms of PE such as high blood pressure and
albuminuria in the last trimester of pregnancy [11,12]. In addition, placenta-induced pathology with
intrauterine growth retardation [12,13], elevated sFlt-1 levels [14], and existing AT1 autoantibodies [15]
are presented in this animal model. Although PE is not caused by a monocausal pathology, this model
reflects appropriately the human aspects of the disease. The use of rodent models such as this will
help us to understand the mechanisms of disease-related alterations in cardiac function and structure
that influence maternal long-term health after a pathological pregnancy. Furthermore, potential novel
preventive and therapeutic strategies can be evaluated. Nevertheless, the gap between animal models
and the human disease is wide, and translational research strategies are warranted to narrow the bridge.
In this study, we tested the hypothesis of whether the transgenic rat model is suitable for the
investigation of the cardiovascular burden after PE. Recently, we showed that the preeclamptic rat
suffers from hypertrophy and diastolic dysfunction [16]. Next, we compared this animal model with
the systolic and the diastolic functions of the human maternal heart after a preeclamptic pregnancy.
Speckle tracking echocardiography (STE), a state-of-the-art technique considered as the gold standard
for early detection of cardiac dysfunction, is the current key tool for the non-invasive measurement
of changes in cardiac function and structure. In this ultrasound imaging technique, the movement
of heart tissue is analyzed using the naturally occurring speckle pattern in the heart muscle or in
the blood. This mixture of interference patterns and natural acoustic reflections makes it possible
to document the movement of the heart muscle by defining vectors and speed. These reflections
are also known as speckles, which have a unique pattern for each region of the myocardium and
make it possible to follow the region from one image to the next. Strain is defined as the percentage
change in the dimension of an object compared to the original shape. Similarly, strain rate can be
defined as the speed at which the deformation occurs. When applied to the LV, the deformation is
defined by the three strains: longitudinal, circumferential, and radial. There is a systolic longitudinal
and circumferential shortening and a radial thickening. Therefore, longitudinal and circumferential
parameters have negative values, whereas radial parameters have positive values.
Formerly preeclamptic women were examined by STE 50 weeks after delivery and compared
with age-matched controls. Transgenic rats were subjected to echocardiography and the same post
processing algorithms four weeks after a preeclamptic pregnancy, which corresponds to two years in
the human situation [17].
2. Results
Speckle tracking echocardiography (STE) was performed four weeks postpartum in formerly
pregnant rats with PE-specific symptoms such as high blood pressure and albuminuria. In comparison,
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the same method was performed in formerly preeclamptic women 50 weeks after delivery
(Figure 1). Both former preeclamptic species (PE) were compared with matched controls after
healthy pregnancy (control).
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Figure 1. Formerly preeclamptic women and rats from a transgenic animal model were characterized
postpartum regarding cardiac alterations in function and structure. Early onset preeclamptic women
showed a lower gestational age than controls but were matched on scanning time after delivery.
2.1. Speckle Tracking Echocardiography in the Transgenic Animal Model Simulates the Human Situation
The most important readout in STE is the global strain data. It describes the degree of deformation
of the myocardium in diffe nt directions. The most sensitive parame er, the global longitu inal strain
(GLS), was reduced after PE n both the animal model (control −23.5 ± 1.8% vs. PE −13.8 ± 0.6%) and
the h man (control −20.6 ± 0.5% vs. PE −15.5 ± 1.6%) postpartum situation (Figure A), and it was the
same regarding the global longitudinal strain rate (Figure 2B) The global radi l strain (Figure 2C) and
the corresponding train rate (Figure 2D) showed only a decreased tendency in the animal post-PE
model and were unchanged in the human situation. The global circumfere tial strain (Figur 2E) and
the corresponding strain rate (Figu 2F) were reduced in the anim l model but showed no changes
after human preeclamptic pregnancy. Moreover, former PE animals d monstrated a cle r reducti n of
the ejection fraction (EF) wi h control 66.3 ± 2.3% vs. PE 55.5 ± 1.3%. The human data confir the
trend (Figure 2G). The stroke volum (Figure 2H) as well as the cardiac output (Figure 2I) and the
end diastolic volume (Figure 2J) were not altered postpartum in any of the species. The end systolic
volume only showed a slight increase in the animal model but not in the human ostpartum situa ion
(Figure 2K). In additi n, echocardi grap y provided t e first initial evidence of morphological chang s.
The posterior wall was clearly th ckened in the nimal post-PE model; in t e human situation, it showed
a borderline p-value of 0.06 (Fi ure 2L). If the relative ll thickness was consid red, both species
showed a postpartum increase (Figur 2M) with control 0.20 ± 0.01 vs. PE 0.25 ± 0.01 in the animal
model and control 0.34 ± 0.01 vs. PE 0.40 ± 0.02 in he h a postpartum situation. Interestingly,
formerly preeclamptic animals showed an increase in LV masses (control 983.5 ± 19.0 mg vs. PE 1138.0
± 40.6 mg); however, form rly preecla ptic women did not (Figure 2N). The LV di meter in the end
diast le was not significantly changed in either species (Figure 2O). The heart rate as significa tly
increased in the animal odel after preeclamptic pregnancy (control 306.6 ± 6.8 bpm vs. PE 356.2 ±
11.0 bpm). Wit a p-value of 0.08, this trend was also evide t in the human situation (Figure 2P).
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Figure 3 summarizes the described measurements in relative changes after a preeclamptic
pregnancy compared to the healthy controls by a spider’s web plot. Here, the examined parameters
are noted in the corners. The controls were normalized to the reference value 1.0, which is shown as
a grey line. Changes in the animal post-PE model are reflected by the red line, and the purple line
refers to the changes in the human post-PE situation compared to healthy controls. Concludingly,
similar deviations after pathological pregnancy in both species can be observed. Several functional
parameters, such as EF, were reduced, and parameters representing structural remodeling, such as
relative wall thickness, were increased in both species compared to controls.
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correlation regarding measurements of EF, r = 0.94, p < 0.0001 (Figure 4E), and GLS, r = 0.98, p < 0.0001
(Figure 4F). Only a minor bias was seen in the corresponding Bland–Altman plots: 0.44 (4.48 to −3.61)
for repeated evaluation of human EF (Figure 4G) and −0.11 (1.36 to −1.58) for human GLS (Figure
4H). The intraclass correlation coefficients (ICCs) for reliability of the evaluations were excellent both
in animal and in human analyses (95% CI): 0.96 (0.89 to 0.99) for animal EF, 0.97 (0.92 to 0.99) for
animal GLS, 0.93 (0.83 to 0.98) for human EF, 0.98 (0.95 to 0.99) for human GLS evaluations.
Figure 3. Relative values of post-preeclamptic changes in the animal model and in the human situation.
Controls of each species were normalized to one. Grey line = controls, purple line = PE human, red line
= PE animal; PE preeclampsia.
2.2. Intraobserver Variability Shows an Excellent Correlation within One Observer
Analyses of the intraobserver variability in the animal data showed an excellent correlation
between two repeated evaluations of EF, r = 0.97, p < 0.0001 (Figure 4A), and GLS, r = 0.98, p < 0.0001
(Figure 4B) within one observer. The very strong agreement between repeated evaluations was
substantiated in the corresponding Bland–Altman plots, which showed only a marginal bias mean
difference (95% CI for limits of agreement): 0.75 (4.50 to −3.00) for EF (Figure 4C) and −0.50 (1.30 to
−2.31) for GLS (Figure 4D). In the human data analyses, there was likewise an excellent intraobserver
correlation regarding measurements of EF, r = 0.94, p < 0.0001 (Figure 4E), and GLS, r = 0.98, p < 0.0001
(Figure 4F). Only a minor bias was seen in the corresponding Bland–Altman plots: 0.44 (4.48 to −3.61)
for repeated evaluation of human EF (Figure 4G) and −0.11 (1.36 to −1.58) for human GLS (Figure 4H).
The intraclass correlation coefficients (ICCs) for reliability of the evaluations were excellent both in
animal and in human analyses (95% CI): 0.96 (0.89 to 0.99) for animal EF, 0.97 (0.92 to 0.99) for animal
GLS, 0.93 (0.83 to 0.98) for human EF, 0.98 (0.95 to 0.99) for human GLS evaluations.
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Figure 4. Intraobserver comparison. In analyses of animal data, there was an excellent correlation between the two repeated evaluations of ejection fraction, r = 0.97, p
< 0.0001 (A), and global longitudinal strain, r = 0.98, p < 0.0001 (B) within one observer. The excellent agreement between the two evaluations was substantiated in the
corresponding Bland–Altman plots, which showed only a marginal bias, mean difference (95% CI for limits of agreement) 0.75 (4.50 to −3.00) for ejection fraction (C)
and −0.50 (1.30 to −2.31) for global longitudinal strain (D). In human data analyses, there was likewise an excellent intraobserver correlation regarding measurements
of ejection fraction, r = 0.94, p < 0.0001 (E), and global longitudinal strain, r = 0.98, p < 0.0001 (F). Only minor bias was seen in the corresponding Bland–Altman plots:
0.44 (4.48 to −3.61) for repeated evaluation of human ejection fraction (G) and −0.11 (1.36 to −1.58) for global longitudinal strain (H). EF = ejection fraction, GLS =
global longitudinal strain.
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2.3. Interobserver Comparison Displays Strong Correlation between Two Different Observers
The interobserver variability comparison showed moderate to strong correlation between the
assessments of the two observers for animal EF (Figure 5A) and GLS (Figure 5B) with a moderate bias,
as shown in the Bland–Altman plots, mean difference (95% CI for limits of agreement) of 1.56 (−4.96
to 8.09) for animal EF (Figure 5C) and −1.01 (−9.30 to 7.28) for animal GLS (Figure 5D). A moderate
to strong correlation was also shown between the assessments of the two observers for human EF
(Figure 5E) and GLS (Figure 5F) with a moderate bias, as shown in the Bland–Altman plots, mean
difference of −4.50 (−12.27 to 3.27) for human EF (Figure 5G) and −1.08 (−5.79 to 3.64) for human GLS
(Figure 5H). The repeatability of the interobserver assessments fluctuated between good ICC (95% CI)
for interobserver animal EF assessments: 0.89 (0.69 to 0.96) and 0.63 (−0.04 to 0.88) for human EF, 0.68
(0.31 to 0.88) for animal GLS, and 0.73 (0.39 to 0.90) for human GLS interobserver assessments.Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 7 of 13 
 
 
Figure 5. Interobserver comparison. In analysis by two experts, variability comparison showed 
moderate to strong correlation between the assessments for animal EF (A) and GLS (B) with a 
moderate bias, as shown in the Bland–Altman plots, mean difference (95% CI for limits of agreement) 
of 1.56 (−4.96 to 8.09) for animal EF (C) and −1.01 (−9.30 to 7.28) for animal GLS (D). A moderate to 
strong correlation was also shown between the assessments of the two observers for human EF (E) 
and GLS (F) with a moderate bias, as shown in the Bland–Altman plots, mean difference of −4.50 
(−12.27 to 3.27) for human EF (G) and −1.08 (−5.79 to 3.64) for human GLS (H).  
3. Discussion 
The aim of this study was to compare cardiac alterations in a transgenic rat model for PE with 
the human post-PE situation. In order to describe cardiovascular changes after pregnancy in both 
species, STE was performed by blinded observers. The reported data reflect equivalent changes in 
the transgenic rat model and the human situation. Functional parameters such as EF and GLS were 
reduced in both species post-PE. We observed an increase in relative wall thickness and an increase 
in the posterior wall thickness of the LV as signs of structural remodeling. Melchiorre et al. were 
among the first who described permanent cardiovascular changes concerning relaxation 
abnormalities, diastolic dysfunction, and alterations according to LV geometry during and after PE 
in humans [4,18,19]. They evaluated LV dysfunction and geometry according to the European 
Association and American Society of Echocardiography guidelines, not mentioning the individual 
parameters that were altered. The novelty of our study is based on the very sensitive method of 
measuring myocardial function using STE. Former preeclamptic women often suffer from 
asymptomatic cardiac abnormalities with prevalence of asymptomatic heart failure stage B including 
concentric remodeling and mildly impaired EF [6]. STE offers more sensitive parameters by 
describing the deformation of the myocardium and is even able to distinguish between individually 
contracting muscle layers of the heart. Previous publications demonstrated the extensive ability of 
STE to differentiate between physiological and pathological hypertrophic changes of the heart [20]. 
With the unique possibility of targeted myocardial specification, STE is being used more frequently 
in animal models [21–23]. The GLS, as the most sensitive parameter, was induced much earlier than 
EF [24] and showed a reduction of cardiac functionality post-PE in both species of our translational 
comparison. To our knowledge, this is the only animal model investigating cardiovascular changes 
postpartum by STE. An important open and unacknowledged question is whether the changes seen 
in humans are reversible [25] or permanent after delivery [26], and, if this is going to be an irreversible 
. Interobserver compariso . In analysis by two experts, variability c mparison showed
t t t l ti n t een the sessments for animal EF ( ) ( ) it moderate
bias, as shown in the Bland–Altman plots, mean difference (95% CI for li its of agreement) of 1.56
(−4.96 to 8.09) for animal EF (C) and −1.01 (−9.30 to 7.28) for animal GLS (D). A moderate to strong
correlation was also shown between the assessments of the two observers for human EF (E) and GLS
(F) with a moderate bias, as shown in the Bland–Altman plots, mean difference of −4.50 (−12.27 to 3.27)
for human EF (G) and −1.08 (−5.79 to 3.64) for human GLS (H).
3. Discussion
The aim of this study was to compare cardiac alterations in a transgenic rat model for PE with
the human post-PE situation. In order to describe cardiovascular changes after pregnancy in both
species, STE was performed by blinded observers. The reported data reflect equivalent changes
in the tra sgenic rat model and the human situation. Function l parameters such as EF and GLS
were reduced in bot species post-PE. We observed an increas relative wall thickness and an
increase in the posterior wall thickness of the LV as signs of structural remodeling. Melchiorre et
al. were among the first who described permanent cardiovascular changes concerning relaxation
abnormalities, diastolic dysfunction, and alterations according to LV geometry during and after PE in
humans [4,18,19]. They evaluated LV dysfunction and geometry according to the European Association
and American Society of Echocardiography guidelines, not mentioning the individual parameters
that were altered. The novelty of our study is based on the very sensitive method of measuring
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myocardial function using STE. Former preeclamptic women often suffer from asymptomatic cardiac
abnormalities with prevalence of asymptomatic heart failure stage B including concentric remodeling
and mildly impaired EF [6]. STE offers more sensitive parameters by describing the deformation of the
myocardium and is even able to distinguish between individually contracting muscle layers of the heart.
Previous publications demonstrated the extensive ability of STE to differentiate between physiological
and pathological hypertrophic changes of the heart [20]. With the unique possibility of targeted
myocardial specification, STE is being used more frequently in animal models [21–23]. The GLS,
as the most sensitive parameter, was induced much earlier than EF [24] and showed a reduction of
cardiac functionality post-PE in both species of our translational comparison. To our knowledge, this
is the only animal model investigating cardiovascular changes postpartum by STE. An important
open and unacknowledged question is whether the changes seen in humans are reversible [25]
or permanent after delivery [26], and, if this is going to be an irreversible remodeling, whether
replacement fibrosis is also present. We observed perivascular and interstitial fibrosis in the transgenic
animal model [16], suggesting that a persisting structural remodeling post-PE and thus permanent
cardiovascular abnormalities after preeclamptic pregnancy might be present after human preeclamptic
pregnancy. Cardiovascular magnetic resonance (CMR) displays a high potential in the detection of
myocardial fibrosis. One of our latest publications about CMR in formerly preeclamptic women
describes the structural remodeling postpartum and underlines the burden of increased cardiovascular
risk in later life. In this four year postpartum study, diffuse injury of the myocardium was assessed by
parametric mapping, focal injury by late gadolinium enhancement imaging, and cardiac function was
evaluated by cine imaging and tissue tracking (strain). The post-preeclamptic group showed increased
left-atrial end-diastolic volume stroke volume with a slight increase in left ventricular hypertrophy.
We could not detect differences in focal or diffuse myocardial tissue composition between the groups.
Follow up studies are needed to identify the critical window when morphologic tissue differentiation,
such as progression to myocardial fibrosis or inflammation, occurs in post-preeclamptic patients.
Beside replacement fibrosis, another indication for permanent alterations in the maternal heart is the
concentric remodeling. LV posterior wall and the extrapolated relative wall thickness increased in this
study in both post-PE species. Intriguingly, the LV mass only increased significantly in the animal
model. However, already published human studies show a permanent hypertrophy of the maternal
heart [4,18,27].
The importance of PE as a risk factor in the development of chronic heart disease has been
reinforced, and the future cardiovascular health of formerly preeclamptic women is getting more and
more attention. Since 2011, the American Heart Association concludes that a pathological pregnancy
is an important novel risk factor for later CVD [1]. While California was the only state in the USA
to reduce maternal mortality due to hemorrhage using disease-specific toolkits and evidence-based
protocol [28], death rates from maternal CVD are rising in the rest of the country. That demonstrates
the urgent need for a cardiovascular follow-up after preeclamptic pregnancy and a preventive strategy
worldwide. New guidelines from the European Society of Cardiology for the management of CVD
during pregnancy [29] recommend lifestyle modifications and annual visits to a primary care physician
to check blood pressure and metabolic factors. A sufficient strategy for cardiovascular prevention
and postpartum treatment is still missing. To investigate the disease related remodeling process of
the maternal heart, animal models are essential. The transgenic rat model mimics a preeclamptic
pregnancy in several important aspects [11–15] and shows characteristic features of cardiac dysfunction
after a preeclamptic pregnancy, as shown in this study.
In conclusion, our data indicate that the transgenic rat model and the use of STE depicts the
cardiovascular abnormalities in the human situation well. That provides the basis investigating the
causes of structural changes and functional disorders and gives the opportunity to test promising
interventions. To underpin the methodical safety, we used one single observer for STE analysis
in both species and demonstrated excellent intraobserver comparison. Interobserver agreements
differed between EF and GLS and underlined the important aspect of fixed observers within a study.
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However, it should be mentioned that preeclampsia is not a monocausal disease, and there is no model
that completely reflects the heterogeneous clinical picture of this disorder. Another limitation is the
postpartum observation time point of four weeks in the animal model. Further studies with longer
postpartum periods corresponding to 10–20 human years will be necessary in the future to be able to
make further statements about the cardiovascular risk after a preeclamptic pregnancy.
4. Materials and Methods
4.1. Animal Cohort
A transgenic rat model was used for simulation of a preeclamptic pregnancy. Female
Sprague-Dawley rats harboring the human angiotensinogen gene [TGR(hAogen)L1623] were mated
with male rats transgenic for the human renin gene [TGR(hRen)L10J] and developed the disease
related phenotype during the last trimester of pregnancy. Age- and body weight-matched
wild-type Sprague-Dawley rats constituted the control group. Both groups were housed in a
temperature-controlled environment of 22 ± 2 ◦C, 12:12-hour light/dark cycle, and a humidity
of 55 ± 15%. The animals had access to water and food (Sniff V1324-300) ad libitum. Rats were
sacrificed 28 days postpartum by decapitation with prior isoflurane anesthesia or due to predefined
stopping. The study was approved by local authorities (G0273/16; State Office of Health and Social
Affairs Berlin).
4.2. Animal Echocardiography
Transthoracic echocardiography in both groups (control n= 8, PE n= 8) was performed postpartum
in anesthetized animals (1.5% isoflurane via an oxygen mask). Temperature, ECG, and respiration
were monitored. By a heated platform, rectal temperature was maintained at 37 ± 2 ◦C. Abdominal
hair was removed by depilatory cream. Pre-warmed gel was used as an ultrasound-coupling medium.
For imaging, a Vevo3100 high-resolution imaging system (Fujifilm, VisualSonics Inc., Toronto, ON,
Canada) mounted with a 21 MHz transducer (MS250) was used. All images were acquired and stored
for offline analysis. Analysis was done by two blinded observers using VisualSonics VevoStrain
software (Version 2.2.0, Toronto, ON, Canada). In parasternal long and short axis view, B-Mode cine
loops were used to assess speckle tracking analysis. Images were checked for quality with regard to
absence of artifacts and differentiation of wall borders. The endocardium of the left ventricle was traced
manually in end-diastole. The epicardium was automatically traced by the software, checked and
manually adjusted if necessary, for maximum tracking accuracy. Global strain values were obtained
from the average of the six segments of the left ventricle. M-mode was obtained to measure cardiac
wall and chamber dimensions. Relative wall thickness was calculated by the formula (2*PWd)/LVEDD.
Analysis was performed on three consecutive cardiac cycles; mean values from three measurements
were calculated.
4.3. Human Cohort
This prospective case-control study was carried out at St. George’s University Hospitals
NHS Foundation Trust in London over a 12-month period from April 2016 until March 2017.
The local institutional review committee approved the study (ID 12/LO/0810; NRES Committee
London—Stanmore; date: 30-06-2012), and all participants provided written informed consent. Women
with singleton pregnancy were recruited as cases. There were no cases of primigravida. Only women
without any cardiovascular co-morbidity and before starting any antihypertensive medication were
asked to take part in the study. Preeclampsia was defined according to the guidelines of the International
Society for the Study of Hypertension in Pregnancy (ISSHP) [30,31]. Normotensive healthy term
pregnant women without any co-morbidity were recruited as controls. Blood pressure was measured
manually from the brachial artery according to the guidelines of the National High Blood Pressure
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Education Program Working Group on High Blood Pressure in Pregnancy [32]. Maternal data of the
human cohort are given in Table 1.
Table 1. Maternal data of human cohort. Cases and controls are matched in age, body mass index
(BMI), and scan time after delivery. Preeclamptic women show lower gestational age of delivery. Data
given as mean ± SEM.
Control (n = 8) Preeclamptic (n = 8) p-Value
Age (years) 36.3 ± 1.71 35.0 ± 1.45 0.5860
Weight (kg) 70.9 ± 5.2 77.8 ± 7.3 0.4569
Height (m) 1.7 ± 0.0 1.6 ± 0.0 0.2014
BMI (kg/m2) 25.1 ± 1.58 28.8 ± 2.17 0.1870
Gestational age of delivery (weeks) 40.4 ± 0.60 31.5 ± 1.49 <0.0001
Scan after delivery (weeks) 45.5 ± 5.45 49.8 ± 3.34 0.5169
4.4. Human Echocardiography
Echocardiographic examination and analysis were performed by a single operator (BSB) using a
GE Vivid Q ultrasound machine equipped with a 3.5 MHz transducer (GE Healthcare, Boston, MA,
USA). Images were acquired at rest in the left lateral decubitus position from standard parasternal and
apical views. Digital loops of 3 cardiac cycles with associated electrocardiogram information were
stored on the hard disk of the ultrasound machine and transferred to a GE EchoPac workstation (GE
Healthcare, Boston, MA, USA) for offline analysis. Analysis was performed according to existing
guidelines [33]. Interventricular septum thickness, left ventricular posterior wall thickness, and left
ventricular systolic and diastolic diameter were measured in the parasternal long axis view. Left atrial
volume (LAV) and left ventricular volume in diastole (LVEDV) were calculated from apical views. Left
ventricular mass was calculated using the Devereux formula 0.8(1.04[([LVEDD + IVSd + PWd]3 −
LVEDD3)]) + 0.6v, where LVEDD is left ventricular end diastolic diameter, IVSd is thickness of the
intraventricular septum in diastole, and PWd is posterior wall thickness in diastole. Relative wall
thickness was calculated with the formula (2*PWd)/LVEDD. For speckle tracking echocardiography,
the myocardium was traced manually, and the EchoPac software then suggested an area of interest by
delimiting the endocardium and the epicardium. The operator readjusted this area before the software
calculated deformation. LV endocardial and epicardial global strain as well as LV longitudinal, LV
early, and LV late diastolic strain rates were calculated from apical views. Negative values indicate
fiber shortening, and positive values indicate fiber lengthening. If >1 segment was rejected, subjects
were excluded from statistical analysis.
4.5. Statistics
Statistical analyses were performed by using SPSS version 25 (IBM, Armonk, NY, USA) and Prism
7.0 software (GraphPad Software Inc., San Diego, CA, USA). ROUT method was performed for outlier
identification with an average false discovery rate less than 1%. After testing for normal distribution
group differences were analyzed by 2-tailed unpaired t-test or by Mann–Whitney U test. All data are
presented as means ± SEM. To describe the quality and the sensitivity of the STE measurements in both
species, intra- and interobserver comparisons were presented for EF and GLS. Intra- and interobserver
variability was assessed on all animals and all study participants by the repeated evaluation of the EF
and GLS. Pearson correlation, Bland–Altman plots, and intraclass correlation were performed to assess
the agreement and the reliability within and between the observers. For interobserver comparison,
two experts evaluated parameters of EF and GLS independently in a blinded manner concerning
the animal model as well as in the human participants. For intraobserver comparison, one observer
repeatedly evaluated EF and GLS in a blinded fashion. Bland–Altman plots were reported including
the mean difference (bias) with corresponding 95% limits of agreement between the evaluations of the
two observers (interobserver agreement) or the repeated evaluations of one observer (intraobserver
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agreement). For the calculation of the intraclass correlation coefficient, a two-way random-effect model
based on single measurements and absolute agreement assessed the interobserver repeatability, and a
two-way mixed-effect model based on single measurements assessed the intraobserver repeatability
for one observer. Mean estimators with 95% confidence intervals (CI) were reported for each ICC.
Interpretation of ICC and Pearson correlation coefficients was elaborated as the following: <0.50 =
poor; between 0.50 and 0.75 = moderate; between 0.75 and 0.90 = strong; >0.90 = excellent. A two-sided
p < 0.05 was considered statistically significant.
5. Conclusions
The use of STE has shown that the transgenic animal model reflects the changes after preeclamptic
pregnancy in a human situation. By applying the state-of-the-art technique STE, especially marginal
changes can be detected due to its sensitivity. This will be of paramount importance for future studies
on the cause of early cardiac remodeling and the evaluation of potential interventions.
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CVD Cardiovascular disease
EF Ejection fraction
GLS Global longitudinal strain
hAogen Human angiotensinogen
hRen Human renin
ICC Intraclass correlation coefficient
IVSd Intraventricular septum diastole
LV Left ventricle
LVEDD Left ventricle end diastolic diameter
ns Non-significant
PE Preeclampsia
PWd Posterior wall diastole
SEM Standard error mean
sFlt-1 Soluble fms-like tyrosine kinase I
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